The FDA has just approved fremanezumab (Ajovy) for the preventive treatment of episodic migraine in children and adolescents ages 6–17. This is a major step forward in giving our youngest patients access to safe, effective, and well-tolerated migraine prevention tailored to their needs. At Synergy Integrative Headache Center, we are committed to offering the most advanced and evidence-based treatments—now with even more options to help kids reclaim their energy, focus, and joy.
Role of magnesium in migraine treatment
Magnesium glycinate offers a promising and well-tolerated option for migraine management. Its high bioavailability and gentle effect on the digestive system make it a suitable choice for many individuals suffering from migraine.
